glp-1 novo Nordisk launches Wegovy weight-loss pill in US, triggering price war | Pharmaceuticals industry The FDA has approved the

Approval: TGA-approved for diabetes

While these medications are highly effective, GLP-1 side effectsespecially gastrointestinal issuescan lead to early discontinuation if not properly addressed

Early findings suggest promising results, but long-term safety data remain limited and are under active investigation

If you inject more than once weekly, use different body areas entirelyfor example, alternate between upper arms one week and abdomen the nextto maximize tissue healing time

In the SURMOUNT-4 trial, withdrawing tirzepatide after initial weight loss led to weight regain, while continued treatment maintained and extended weight reduction